HOME >> BIOLOGY >> NEWS
Ohio State scientists bake heart healthy soy bread

COLUMBUS, Ohio - A team of scientists at The Ohio State University has somethin' in the oven: the first soy bread that's both good for your heart and easy on the taste buds, too.

"This is the first baked good that can legitimately carry the FDA claim that consuming it is associated with a lower risk of heart disease," says Dr. Yael Vodovotz, an assistant professor of food science. "It's a big deal."

It's an even bigger deal that people actually like the bread.

"The problem with soy products is that they just don't taste good to a lot of people," says Vodovotz. "They sometimes have that beany flavor."

The world is full of soy products-everything from soy milk and soy cookies to soy candles and crayons, but nothing is as ubiquitous as bread. For Vodovotz, it became the Holy Grail - to develop an affordable product that could be happily consumed every day, last a long time, and most importantly, taste good. Bingo. Bread.

Vodovotz says the bread is a little dense and chewy, and looks very much like white bread. Just to get the numbers straight, the FDA says in order to get the heart-healthy benefits of soy, consumers have to eat at least 25 grams of soy protein daily. For a soy product to meet this claim, a serving needs to provide 6.25 grams of soy protein, as well as be low in fat, low in saturated fat, and low in cholesterol. Vodovotz says their soy bread meets all of those requirements.

She and one of her students, Cory Ballard, a food scientist who is also a baker by trade, have been working on the secret soy bread recipe for months. They've field tested it at local grocery stores, and are currently negotiating an agreement to license the product to a bakery in Cleveland. It's a family-owned business that bakes and markets to grocery stores in four states. It could be just the beginning. Because soy has shown demonstrable success in preventing some kinds of cancers, "everyone wants to use it," say
'"/>

Contact: Michelle Gailiun
gailiun.1@osu.edu
614-293-3737
Ohio State University Medical Center
6-Dec-2001


Page: 1 2 3

Related biology news :

1. New Arizona State center brings science to policy on issues of water resources and urban growth
2. K-State, other universities to study how climate affects plant evolution
3. K-States National Agricultural Biosecurity Center receives $1.3 Million from Department of Defense
4. K-State professor combines love of teaching, research to examine eye development
5. K-State researcher working to improve alternatives to equine antibiotics
6. Lung cancer patients in Japan, United States react differently to the same chemotherapy regimen
7. K-State business researchers to help with major study on food supply veterinary medicine
8. K-State researchers share $1 million grant to study insect pests
9. UC Riverside professor to spend year with US State Department
10. American Lung Associations 2004 State of the Air report ranks cities and counties with dirty air
11. K-State soil carbon sequestration research playing role in climate change efforts

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ohio State scientists bake heart healthy soy bread

(Date:5/19/2015)... May 18, 2015 Fingerprint Cards (FPC) ... FPC1025, FPC1145, FPC1155 and FPC1035 from one if its module ... and including Q3 2015 and the sensors will be used ... order values for 2015 hereby amount to 740 MSEK to ... of 140 MSEK and a number of smaller orders not ...
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
(Date:5/14/2015)... and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has announced ... Smart Mobile Devices " report to their offering. ... watershed year for fingerprint sensors in smartphones and tablets, ... fingerprint sensors a raison d,etre in the mobile milieu ... must-have feature in flagship smartphones. The key ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
(Date:5/21/2015)... , May 21, 2015  The EveryLife ... Hatch (R-UT) and Amy Klobuchar ... Now Accelerating Cures & Treatments, or OPEN ACT. ... disease patient advocacy organizations, this bipartisan legislation promises ... affordable medicines to rare disease patients by incentivizing ...
(Date:5/21/2015)... May 21, 2015  CytRx Corporation (NASDAQ: ... specializing in oncology, today announced positive updated results ... aldoxorubicin for the treatment of unresectable glioblastoma multiforme ... open-label, multisite trial is designed to investigate the ... whose tumors have progressed following prior treatment with ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Veolia’s ... an exclusive North American distribution agreement with VWR ... system. , With more than 160 years of ... and services for laboratory and production facilities, has ... excellence and differentiated services to enable science. ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 This year ... especially for lawns. US Patented Pearl’s Premium Ultra ... lawns around the country that are coming out of ... addresses a number of major global concerns related to ... “non-grass” grass – the alternative to the standard, water-wasting, ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2
Cached News: